DNA Quantification: UV, Fluorometry, Slot-Blot and qPCR

The PCR-based STR kits used in operational forensic laboratories are calibrated for an input of roughly 0.5 to 1 ng of human genomic DNA per amplification reaction. Both over-loading and under-loading produce artefacts. Over-loading generates off-scale peaks, pull-up, elevated stutter, and in the worst cases activates inhibition mechanisms that truncate the profile at larger loci. Under-loading introduces stochastic effects: allelic drop-out, peak-height imbalance, and heterozygote imbalance that can be misread as homozygosity or mixture contribution.

In the United States, the FBI Quality Assurance Standards for Forensic DNA Testing Laboratories (revised 2020) require that each sample be quantified before PCR amplification, with the method and result documented in the case file. The UK Forensic Science Regulator's Codes of Practice, Annex D (2023), impose an equivalent requirement, specifying that laboratories must validate the quantitation method for the sample types and DNA input ranges they routinely process. Germany's Bundeskriminalamt (BKA) and the Netherlands Forensic Institute (NFI) operate under the EN ISO/IEC 17025 framework, which treats quantitation as a required step in the validated workflow. In India, NABL-accredited central and state forensic science laboratories are moving towards the same requirement as part of alignment with ISO 17025 and the draft SWGDAM-equivalent guidelines proposed under the DNA Technology (Use and Application) Regulation Bill 2019.

Ultraviolet absorbance spectrophotometry exploits the fact that the purine and pyrimidine bases in nucleic acids absorb strongly at 260 nm, while proteins absorb at 280 nm and organic solvents at 230 nm. A spectrophotometer measures absorbance at each wavelength and applies the Beer-Lambert law; for double-stranded DNA the conversion factor is 50 µg/mL per absorbance unit at 260 nm.

The Thermo Scientific NanoDrop 2000 and its successors (NanoDrop One, NanoDrop 8000 for high-throughput) require only 1 to 2 µL of sample, operate without cuvettes by measuring across a fibre-optic gap, and return a reading in under 5 seconds. These properties make the NanoDrop the instrument of choice for rapid purity screening: an A260/A280 ratio between 1.7 and 1.9 indicates acceptably pure DNA; values below 1.7 suggest residual protein contamination. An A260/A230 ratio below 1.5 indicates residual organic solvent, guanidine salts from silica-column extraction, or other co-purification contaminants that may later inhibit PCR.

However, UV absorbance has two critical weaknesses in a forensic context. First, it is not species-specific. A swab recovered from a surface heavily contaminated with bacterial biofilm or plant material will report a high DNA concentration that almost entirely reflects non-human DNA. Second, it detects all absorbing material at 260 nm, including RNA, free nucleotides, and partially degraded DNA; the result will therefore over-estimate the amount of intact, amplifiable human DNA. The sensitivity threshold of approximately 1 ng/µL is also poor by forensic standards, many casework samples produce extracts well below this concentration.

In practice, UV absorbance on a NanoDrop is used in forensic workflows primarily as a purity check on DNA extract quality after isolation and before the more specific quantitation step, or as a rapid check in a research or method-development context. US, UK and EU accreditation auditors accept it as a supplementary tool but require a human-specific method for the primary quantitation decision on case samples.

Fluorometric quantitation works by adding a fluorescent dye that intercalates specifically into double-stranded DNA (dsDNA); the fluorescence intensity is then directly proportional to dsDNA concentration. Because the dye does not bind meaningfully to single-stranded nucleic acids, RNA, free nucleotides, or most common contaminants, the signal is considerably more selective than UV absorbance.

PicoGreen (Quant-iT PicoGreen dsDNA reagent, Thermo Fisher Scientific) was the original plate-reader format: the dye is mixed with the sample in a microplate well, and fluorescence is measured against a standard curve run in parallel. The linear range spans approximately 25 pg/mL to 1 µg/mL, giving PicoGreen a sensitivity roughly 100-fold greater than the NanoDrop. PicoGreen-based quantitation became a standard component of automated high-throughput forensic workflows on platforms such as the Biomek liquid-handler and the Hamilton STAR in the mid-2000s, particularly in national reference laboratories and cold-case reprocessing programmes.

The Qubit 4 Fluorometer (Thermo Fisher Scientific) packages the same principle in a single-tube, benchtop format. The operator loads 1 to 20 µL of sample into a Qubit assay tube with a pre-mixed dye-buffer cocktail, vortexes briefly, and reads the result against two standards within 30 seconds. The dsDNA HS (High Sensitivity) assay covers 0.1 to 120 ng/µL; the dsDNA BR (Broad Range) assay covers 2 to 1,000 ng/µL. The instrument is widely adopted in forensic laboratories across Australia (Victoria Police Forensic Services and NSW Police Forensic Laboratories both run it), New Zealand, Canada (Centre of Forensic Sciences, Toronto), South Africa (SAPS Forensic Science Laboratory), and India (Central Forensic Science Laboratory, Hyderabad). Its simplicity makes it appropriate for satellite or regional laboratories where a plate-reader format would be impractical.

The key limitation shared by all fluorometric methods is, again, species non-specificity. A PicoGreen or Qubit result tells the examiner how much total dsDNA is present; it cannot separate human from canine from bacterial. For this reason, fluorometry is typically used as a preparatory check or as the quantitation step in cases where the sample source is unambiguous (a reference buccal swab, a pristine blood stain), rather than as the sole quantitation method for complex casework samples.

Slot-blot hybridisation achieves human specificity by using a labelled probe that binds selectively to a repetitive element in the human genome. The QuantiBlot Human DNA Quantitation System (Applied Biosystems) is built around a probe directed at the D17Z1 alpha-satellite repeat on chromosome 17. Because this repeat is human-specific and present in hundreds of copies per haploid genome, the probe hybridises only to human DNA, ignoring bacterial, fungal, or plant co-contaminants.

The procedure involves denaturing sample and standard DNA, spotting known quantities onto a nylon membrane using a vacuum manifold (the "slot-blot" format), cross-linking by UV or baking, hybridising with the labelled probe, washing, and detecting colorimetrically or by chemiluminescence. The analyst compares the sample spot density against a standard curve of known concentrations to estimate the amount of human DNA.

The QuantiBlot system was developed in the early 1990s at the FBI Laboratory and was quickly adopted by forensic laboratories in the United States, Canada, and several European national services before qPCR-based methods became accessible. In the 1995 O.J. Simpson trial in the United States, the DNA evidence from the LAPD laboratory had been processed using slot-blot quantitation, and the procedure became the subject of cross-examination; the courtroom standards that govern such challenges are examined in admissibility and ethics: Daubert, Frye and ELSI. Slot-blot also preceded the shift to silica-column and magnetic-bead extraction in most accredited laboratories. German BKA and UK FSS (Forensic Science Service) laboratories used QuantiBlot-based approaches through the early 2000s. In India, several central and state FSL protocols from the 2000s and early 2010s reference the slot-blot format before the transition to qPCR.

Practical limitations are significant. The assay is semiquantitative (the linear dynamic range is approximately 0.5 to 50 ng per spot), labour-intensive, prone to pipetting variation between spots, and generates chemiluminescent waste. It provides no information about degradation status. These factors, combined with the superior performance of qPCR-based kits, mean that slot-blot has largely been replaced in high-throughput accredited laboratories, though it remains appropriate in settings where qPCR infrastructure is not available or where a rapid human-specific screen is needed without a real-time PCR platform.

Real-time PCR quantitation works by amplifying a short target sequence and measuring the fluorescence signal generated as the reaction proceeds, cycle by cycle. The cycle at which fluorescence crosses a threshold (the Cq or Ct value) is inversely proportional to the starting concentration of target DNA. A standard curve of known concentrations, run in the same plate, converts Cq values to ng/µL. In a forensic qPCR kit, the target sequence is human-specific (directed at a repetitive element or a conserved autosomal locus absent from most non-human genomes), so only human DNA contributes to the signal.

The Quantifiler Trio Kit (Applied Biosystems / Thermo Fisher Scientific) has become a global reference standard since its introduction in 2014. It runs three assays simultaneously in a single well: a small autosomal target (SS, around 80 bp amplicon) targeting a repetitive element for total human nuclear DNA concentration, a large autosomal target (LS, around 214 bp amplicon) that reports intact high-molecular-weight DNA, and a Y-chromosome target that provides male DNA concentration and an estimate of the male fraction in mixed samples. The ratio of LS/SS signal is the Degradation Index (DI): a DI above approximately 3 flags a sample as degraded and triggers consideration of a low-template or degraded-sample amplification protocol. The kit is validated for the ABI 7500 Real-Time PCR System and the QuantStudio 5 (both Applied Biosystems). FBI-accredited US laboratories, the UK's Key Forensic Services and Eurofins Forensic Services, and numerous European national laboratories now run Quantifiler Trio as the primary quantitation method.

Plexor HY (Promega Corporation) uses a different chemistry: a modified primer incorporating an isoguanosine residue that is quenched when the complementary isocytidine-labelled nucleotide is incorporated during extension. The result is a decrease in fluorescence proportional to amplification, which is converted to concentration using the same Ct-standard-curve logic. Plexor HY targets a Y-chromosome locus for male fraction and an autosomal locus for total human DNA. Promega also offers the PowerQuant System, which includes the same degradation-index concept as Quantifiler Trio. Plexor HY is widely used in Australian state forensic laboratories (including the Victorian Institute of Forensic Medicine), the Royal Canadian Mounted Police (RCMP) National Forensic Laboratory Services, and several Scandinavian national services.

InnoQuant HY (Innovative Forensics / Yamazaki Industries, Japan) adds IPC (Internal PCR Control) spike-in technology to detect inhibition, and provides autosomal and Y quantitation with a degradation index. It is the primary human-specific quantitation kit in several Japanese prefectural forensic laboratories and has adoption in South Korean and Taiwanese forensic services.

All three kits are run with a positive control (human genomic DNA of known concentration), a negative control (reagent blank with no template), and, in most validated workflows, an IPC reaction to detect PCR inhibition. The ABI 7500 Fast Real-Time PCR System processes a 96-well plate in approximately 40 minutes; the QuantStudio 5 in fast-plate mode achieves similar throughput. For very high-throughput national database operations, the ABI 7900HT (384-well) and QuantStudio 12K Flex are used.

Accredited forensic laboratories do not choose one quantitation method in isolation; they choose a validated workflow that specifies the primary quantitation method, any secondary check, and the decision rules that follow from the result. The table below summarises the operational positioning.

For a typical casework swab arriving at a US, UK, or EU accredited laboratory, the validated SOP will specify: (1) extract DNA using a validated extraction method, (2) run a NanoDrop purity check and discard the result if A260/A280 is outside the acceptable range, (3) run the Quantifiler Trio kit on the ABI 7500 against the validated standard curve, (4) apply the decision rules (input volume for 0.5 ng target, flag DI greater than 3 for degraded protocol, flag male fraction for Y-specific interpretation). In Australian laboratories following ANAB (American National Accreditation Body) or NATA (National Association of Testing Authorities) requirements, the same logic applies with Plexor HY or PowerQuant as the kit.

For reference buccal swabs, where the source is known, the sample is fresh, and inhibition is unlikely, some validated workflows permit the use of a Qubit dsDNA HS assay as the primary quantitation step, accepting the loss of species specificity in exchange for simplicity and throughput. This is documented in the SWGDAM Interpretation Guidelines and in validation studies published in Forensic Science International: Genetics, including a 2019 study from the Centre of Forensic Sciences, Toronto, and a 2021 study from the German LKA Bayern laboratory.

1. Extract DNA
   Validated extraction method (organic, Chelex, silica-column, or magnetic-bead). Elute into low-TE or water buffer.
2. Purity check (optional)
   NanoDrop measurement. Flag extracts with A260/A280 below 1.7 or A260/A230 below 1.5 for re-extraction or dilution.
3. Human-specific qPCR
   Quantifiler Trio, Plexor HY, or InnoQuant HY on validated real-time PCR platform. Include positive control, negative control, and standard curve.
4. Apply decision rules
   Calculate ng/µL for autosomal and Y targets. Compute Degradation Index. Select amplification input volume (0.5 ng default, adjust for DI and inhibition flags).
5. Document and proceed
   Record quantitation result in the case file. Route sample to standard STR, degraded-sample, or low-template protocol based on the result.